Literature DB >> 1620460

[Postoperative cerebral edema. Physiopathology of the edema and medical therapy].

C Tommasino1.   

Abstract

Cerebral edema complicates many neurosurgical conditions, such as head injuries, neoplasms and infections, and is the direct result of operative trauma. The recognition and the treatment of brain edema are of great practical importance, particularly in those conditions leading to brain herniations and/or intracranial hypertension. Brain edema can be distinguished into two major categories, based on the integrity of the blood brain-barrier (BBB). With intact BBB edema, the crucial pathogenic event is related to disturbances of cellular metabolism and ionic transport. All the cellular elements of brain may undergo swelling, with a concomitant reduction of the extracellular-fluid space of the brain. Open BBB edema, the most common form of brain edema, is characterized by increased permeability of the brain endothelial cells. Brain edema results from the oncotic forces generated from a serum protein influx into the nervous tissue, and edema fluid accumulates primarily in the extracellular space. The non-operative management of brain edema requires attention to the causes that have induced brain edema. Specific pharmacologic therapy with corticosteroids, hyperosmolar agents and furosemide or acetazolamide depend upon accurate assessment of BBB integrity.

Entities:  

Mesh:

Year:  1992        PMID: 1620460

Source DB:  PubMed          Journal:  Minerva Anestesiol        ISSN: 0375-9393            Impact factor:   3.051


  4 in total

Review 1.  Neuroprotection against surgically induced brain injury.

Authors:  Vikram Jadhav; Ihsan Solaroglu; Andre Obenaus; John H Zhang
Journal:  Surg Neurol       Date:  2007-01

2.  Dual effects of melatonin on oxidative stress after surgical brain injury in rats.

Authors:  Steve Lee; Vikram Jadhav; Robert E Ayer; Hugo Rojas; Amy Hyong; Tim Lekic; Jiping Tang; John H Zhang
Journal:  J Pineal Res       Date:  2008-06-18       Impact factor: 13.007

3.  NADPH oxidase inhibition improves neurological outcomes in surgically-induced brain injury.

Authors:  Wendy Lo; Thomas Bravo; Vikram Jadhav; Elena Titova; John H Zhang; Jiping Tang
Journal:  Neurosci Lett       Date:  2007-01-11       Impact factor: 3.046

4.  Rosiglitazone, a PPAR gamma agonist, attenuates inflammation after surgical brain injury in rodents.

Authors:  Amy Hyong; Vikram Jadhav; Steve Lee; Wenni Tong; Jamaine Rowe; John H Zhang; Jiping Tang
Journal:  Brain Res       Date:  2008-04-22       Impact factor: 3.252

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.